Blood Flow Restriction Therapy Preserves Lower Extremity Bone and Muscle Mass After ACL Reconstruction.

After ACL reconstruction, muscle wasting and even bone loss around the knee are common, and rehabilitation teams have looked for ways to limit that decline while patients rebuild strength. This trial compared standard 12-week rehabilitation alone against the same program with blood flow restriction therapy added during select exercises, in which a tourniquet partially limits blood flow to the operated leg during low-load exercise. In the group receiving standard rehabilitation only, lean mass and bone mass in the operated leg both dropped at 6 and 12 weeks compared with before surgery, along with reductions in bone density at specific sites including the upper shin and fibula.

The group receiving blood flow restriction did not show these same reductions, and this group also returned to sport sooner on average, though functional test scores were similar between groups. The main limitation is the small size of the trial, 32 patients total, which limits how confidently these findings can be generalized to wider ACL rehabilitation practice.

If you or someone you know is recovering from ACL surgery, muscle and even bone loss in the leg is a well-known part of the recovery process, especially in the early weeks. This study looked at whether adding a technique called blood flow restriction therapy, where a cuff partially limits blood flow to the leg during light exercise, could help protect against that loss compared with standard rehabilitation alone. Over 12 weeks, patients doing standard rehabilitation without the blood flow restriction technique lost measurable muscle and bone in the surgical leg.

Patients who had blood flow restriction added to their exercises did not show these same losses, and on average they returned to sport sooner, though both groups performed similarly on functional tests. This is encouraging preliminary evidence, but it comes from a small trial of only 32 people, so it can't tell us how reliably these results would hold up in a larger, more diverse group of patients recovering from this surgery.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This trial addresses a question that comes up often in ACL reconstruction rehabilitation: can blood flow restriction training, added to standard low-load exercise, meaningfully limit the muscle and bone loss that typically follows surgery and bone-patellar tendon-bone autograft harvest. Using DEXA imaging at presurgery, week 6, and week 12, the standard rehabilitation group showed significant reductions in lower extremity lean mass and bone mass at both timepoints, along with site-specific bone mineral density losses at the proximal tibia and fibula.

These reductions were not observed in the blood flow restriction group, and return to sport time was shorter in that group (6.4 versus 8.3 months), though functional testing outcomes were comparable between groups. The contribution here is specific: this is within- and between-group evidence on tissue-level outcomes (bone and lean mass) rather than a definitive functional superiority trial, since objective function measures did not differ. The return-to-sport finding is notable but secondary to the primary bone and muscle outcomes, and should be interpreted with that hierarchy in mind. With only 15 and 17 patients per arm, this remains a small randomized trial, and while no complications were reported, the modest sample limits confidence in how broadly these tissue-preserving effects would generalize across surgical techniques, grafts, or rehabilitation settings.